NexImmune, Inc.

📍 Gaithersburg, United States🗓 Founded 2011👥 37 employees💰 Last funded Jan 2021
Biotechnology Research🌐 neximmune.com
Website LinkedIn
NexImmune is a publicly traded, clinical stage biotechnology company developing unique approaches to T cell immunotherapies based on its propriety Artificial Immune Modulation (AIM™) technology. NexImmune has a differentiated platform and pipeline of product candidates in pre-clinical and phase 1/2 stages with lead programs focused on the treatment of relapsed acute myeloid leukemia (AML) after allogenic stem cell transplantation and multiple myeloma refractory to >3 prior lines of therapy. The AIM technology enables NexImmune to construct nanoparticles that function as synthetic dendritic cells capable of directing a specific T cell-mediated immune response. By mimicking natural T cell biology, NexImmune’s T cell product candidates are designed to combine the attributes of cellular precision, potency, and persistence with reduced potential for undesired toxicities. For the last decade, the AIM platform has evolved into a stable platform for various therapy targets providing an opportunity to make a massive impact due to its adaptability and flexibility in oncology, autoimmune disorders, infectious disease, and beyond.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2011
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Late stage· 2
Matthew C.
Matthew C.
Venture Capital
late stage
3 investments
Jan 2021
?
Board Member
late stage
2018
Investor geography1 country
United States
1
Frequently asked questions
Who invested in NexImmune, Inc.?
NexImmune, Inc. has 2 investors on record on gritt.io and 2 late-stage investors.
When did NexImmune, Inc. last raise funding?
The most recent investment in NexImmune, Inc. recorded on gritt.io was in January 2021.
When was NexImmune, Inc. founded?
NexImmune, Inc. was founded in 2011.
What industry is NexImmune, Inc. in?
NexImmune, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NexImmune, Inc. based?
NexImmune, Inc. is headquartered in Gaithersburg, United States.